Cargando…
Evaluating the Evidence behind the Novel Strategy of Early Combination from Vision to Implementation
Type 2 diabetes mellitus (T2DM) is a complex and progressive chronic disease characterised by elevating hyperglycaemia and associated need to gradually intensify therapy in order to achieve and maintain glycaemic control. Treating hyperglycaemia with sequential therapy is proposed to allow holistic...
Autor principal: | Paldánius, Päivi Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801764/ https://www.ncbi.nlm.nih.gov/pubmed/33081426 http://dx.doi.org/10.4093/dmj.2020.0179 |
Ejemplares similares
-
Exploring early combination strategy in Latin American patients with newly diagnosed type 2 diabetes: a sub-analysis of the VERIFY study
por: Vencio, Sérgio, et al.
Publicado: (2021) -
Dipeptidyl Peptidase-4 Inhibitor Development and Post-authorisation Programme for Vildagliptin — Clinical Evidence for Optimised Management of Chronic Diseases Beyond Type 2 Diabetes
por: Strain, William David, et al.
Publicado: (2017) -
Street photography: creative vision behind the lens
por: Jardin, Valérie
Publicado: (2018) -
Scientific information overload in vision: What is behind?
por: Piñero, David P.
Publicado: (2018) -
Insights from VERIFY: Early Combination Therapy Provides Better Glycaemic Durability Than a Stepwise Approach in Newly Diagnosed Type 2 Diabetes
por: Matthews, David, et al.
Publicado: (2020)